Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
233-239
Author(s):
Giuseppe Cirino, Vincenzo Santagada and Giuseppe Caliendo
Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance Mutations
Journal:
Current Drug Metabolism
Volume:
3
Page:
73-95
Author(s):
Giovanni Maga and Silvio Spadari
Benzodiazepine Discontinuation Difficulties in Panic Disorder: Conceptual Model and Outcome for Cognitive-Behavior Therapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
75-80
Author(s):
M. W. Otto, J. J. Hong and S. A. Safren
The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
293-300
Author(s):
R.O. Dillman
Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
301-311
Author(s):
A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White
Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
201-208
Author(s):
Moiz Bakhiet
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Designing Peptide Mimetics for the Treatment of Multiple Sclerosis
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
273-282
Author(s):
J. Matsoukas, V. Apostolopoulos and T. Mavromoustakos
Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
171-199
Author(s):
Zafar H. israili
Molecular Basis for Designing Selective Modulators of Retinoic Acid Receptor Transcriptional Activities
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
153-164
Author(s):
P. Lefebvre